Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.
Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F, Gargaro M, Manni G, Pirro M, Xu S, Sadeghi M, Nabavi SF, Shirooie S.
Jahanban-Esfahlan R, et al.
Rev Med Virol. 2019 Jul;29(4):e2048. doi: 10.1002/rmv.2048. Epub 2019 Jul 2.
Rev Med Virol. 2019.
PMID: 31265195
Review.